Showing results (961-970 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|October 17, 2021
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.Transplantation and Cellular Therapy|October 4, 2021
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell TransplantationMegan Kinzel, Michelle Dowhan, Amit Kalra, et al.Transplantation and Cellular Therapy|October 4, 2021
Effect of Donor NKG2D Polymorphism on Relapse after Haploidentical Transplantation with Post-Transplantation CyclophosphamideKentaro Ido, Hideo Koh, Asao Hirose, et al.Transplantation and Cellular Therapy|May 5, 2022
Comparisons of Modified Post-Transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor/Antithymocyte Globulin Regimens for Haploidentical Stem Cell Transplantation in Patients with Aplastic AnemiaYun Li, Xuan Lu, Na Wang, et al.Transplantation and Cellular Therapy|April 27, 2022
Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell TransplantationEleni Karantoni, Phaedon D Zavras, Yiqi Su, et al.Transplantation and Cellular Therapy|July 21, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.Transplantation and Cellular Therapy|July 23, 2022
Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working PartySimone Cesaro, Jean Donadieu, Marco Cipolli, et al.Transplantation and Cellular Therapy|April 23, 2022
Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow TransplantationEmmanuel Katsanis, Baldassarre Stea, Kristen Kovacs, et al.Transplantation and Cellular Therapy|April 30, 2022
Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell TransplantationAbdelrahman Saqr, Brooke Carlson, Christopher Staley, et al.Transplantation and Cellular Therapy|February 21, 2022
The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework AnalysisBenjamin Andrick, Lorraine Tusing, Laney K Jones, et al.Pageof 183